References
- Ackenheil M., Beckmann H., Griel W., Hoffmann G., Markianos E., Raese J. Anti-psychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man; the phenothiazines and structurally related drugs. Advances in Biochemical Psychopharmacology Volume 9, I. S.C. J. Forrest Carr, E. Osden. Raven Press, New York 1974
- Gros H., Langer E. Das wirkungsprofil eines chemisch neuartigen breitbandneuroleptikums der dibenzodiazepringruppe. Wiener Medizinische Wochenschrist 1965; 116: 814
- Honigfeld G., Klett J. The Nurses' Observation Scale for In-Patient Evaluation (N.O.S.I.E.). Journal of Clinical Psychology 1965; 21: 65
- Matz R., Rick W., Oh D., Thompson H., Gershon S. Clozapine—a potential antipsychotic agent with extra-pyramidal manifestations. Current Therapeutic Research 1974; 10: 799
- Overall J. E., Gorham D. R. The brief psychiatric rating scale (B.P.R.S.). Psychology 1962; 10: 739
- Shopsin B. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients. Current Therapeutic Research 1972; 14: 739
- Simpson G. M., Varga E. Clozapine: a new antipsychotic agent. Current Therapeutic Research. 1974; 16: 679